Dr Vijay Agarwal | Lorlatinib as a first line option for ALK positive metastatic NSCLC 

Cancer Research And Statistic Foundation organized a webinar "Lung Cancer Update" with the support of "Institute of Pulmonology Medical Research & Development" & "Sunrise Oncology Centre".
Date: 18 February 2022
Time: 07:00 pm to 09:00 pm
Follow us:
CRSF Online: crsf.in/
Facebook: bit.ly/3QfMTrX
Twitter: bit.ly/3vBQAR7
LinkedIn: bit.ly/3zVG7m8
Event Managed By:
Horizon Conference Management
#crsf #LungCancer #Oncology #OncoCare